BofA raised the firm’s price target on Ameren (AEE) to $101 from $99 and keeps a Neutral rating on the shares. BofA expects Ameren to report flat Q2 EPS vs. the prior year quarter, reflecting more normal weather, higher rates and demand growth, and higher operating expenses, the analyst tells investors. The firm expects management to provide a regulatory update addressing both federal legislation and regulatory activity in Illinois and Missouri, and does not expect any change in financial guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEE:
- Ameren price target raised to $114 from $111 at UBS
- Ameren price target lowered to $100 from $104 at Barclays
- Ameren upgraded to Neutral from Sell at Goldman Sachs
- Ameren price target lowered to $100 from $102 at Morgan Stanley
- Trump Trade: U.S. President says China getting 10% tariffs in ‘done’ deal